Clinical Trial Regs: FDA Seeks Advice On How To Make Them Better, Faster, Stronger

FDA is holding a two-day public hearing to get input on how to modernize its regulation of clinical trials; stakeholders cite need for innovative trial design, data sharing, guidance on use of biomarkers.